XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Note 4 - Stock-based Compensation
9 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
4.
Stock-Based Compensation
 
The Company accounts for its stock-based compensation at fair value. The following table summarizes stock-based compensation expense by financial statement line item for the 
three
and
nine
months ended 
December 31, 2020
and 
2019
(in thousands):
 
   
Three Months Ended December 31,
   
Nine Months Ended December 31,
 
   
2020
   
2019
   
2020
   
2019
 
Cost of revenues   $
(23
)   $
21
    $
35
    $
45
 
Research and development    
179
     
117
     
470
     
219
 
Selling, general and administrative    
683
     
452
     
2,092
     
971
 
Total
  $
839
    $
590
    $
2,597
    $
1,236
 
 
The Company issued 
27,341
shares of immediately vested common stock and 
697,167
shares of restricted stock awards during the
nine
months ended 
December 31, 2020
and issued
13,174
 shares of immediately vested common stock and
366,000
 shares of restricted stock awards during the
nine
months ended
December 31, 2019
.  These restricted stock awards generally vest over
2
-
3
years.  Awards for restricted stock include both time-based and performance-based awards.  For options and restricted stock awards that vest upon the passage of time, expense is being recorded over the vesting period.  Performance-based awards are expensed over the requisite service period based on probability of achievement.
 
The estimated fair value of the Company's stock-based awards, less expected annual forfeitures, is amortized over the awards' service period. The total unrecognized compensation cost for unvested outstanding stock options was less than $
0.1
million at
December 31, 2020
. This expense will be recognized over a weighted average expense period of approximately 
0.4
years. The total unrecognized compensation cost for unvested outstanding restricted stock was $
5.2
million at
December 31, 2020
. This expense will be recognized over a weighted-average expense period of approximately 
1.9
years.
 
The Company did
not
grant any stock options during the
nine
 months ended 
December 31, 2020
.  The Company granted
5,939
 stock options during the 
nine
months ended
December 31, 2019
.  The stock options granted during the
nine
months ended 
December 31, 2019
will vest over
2
ye
ars. The weighted average assumptions used in the Black Scholes valuation model for stock options granted during the 
nine
months ended 
December 31, 2019
are as follows:
 
   
Three Months Ended December 31,
   
Nine Months Ended December 31,
 
   
2020
   
2019
   
2020
   
2019
 
Expected volatility
   
N/A
     
N/A
     
N/A
     
66.5
%
Risk-free interest rate
   
N/A
     
N/A
     
N/A
     
1.8
%
Expected life (years)
   
N/A
     
N/A
     
N/A
     
5.91
 
Dividend yield
   
N/A
     
N/A
     
N/A
   
None